These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 14971051

  • 1. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.
    Vollmer J, Weeratna R, Payette P, Jurk M, Schetter C, Laucht M, Wader T, Tluk S, Liu M, Davis HL, Krieg AM.
    Eur J Immunol; 2004 Jan; 34(1):251-62. PubMed ID: 14971051
    [Abstract] [Full Text] [Related]

  • 2. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J, Weeratna RD, Jurk M, Davis HL, Schetter C, Wüllner M, Wader T, Liu M, Kritzler A, Krieg AM.
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [Abstract] [Full Text] [Related]

  • 3. C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level.
    Jurk M, Schulte B, Kritzler A, Noll B, Uhlmann E, Wader T, Schetter C, Krieg AM, Vollmer J.
    Immunobiology; 2004 Sep; 209(1-2):141-54. PubMed ID: 15481148
    [Abstract] [Full Text] [Related]

  • 4. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
    Hartmann G, Battiany J, Poeck H, Wagner M, Kerkmann M, Lubenow N, Rothenfusser S, Endres S.
    Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
    [Abstract] [Full Text] [Related]

  • 5. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
    Vollmer J, Weeratna RD, Jurk M, Samulowitz U, McCluskie MJ, Payette P, Davis HL, Schetter C, Krieg AM.
    Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
    [Abstract] [Full Text] [Related]

  • 6. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A, Calcaterra C, Mènard S, Balsari A.
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [Abstract] [Full Text] [Related]

  • 7. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER, Bhagat L, Li Y, Yu D, Wang D, Cong YP, Song SS, Tang JX, Sullivan T, Agrawal S.
    Proc Natl Acad Sci U S A; 2005 May 10; 102(19):6925-30. PubMed ID: 15860583
    [Abstract] [Full Text] [Related]

  • 8. Bovine toll-like receptor 9: a comparative analysis of molecular structure, function and expression.
    Griebel PJ, Brownlie R, Manuja A, Nichani A, Mookherjee N, Popowych Y, Mutwiri G, Hecker R, Babiuk LA.
    Vet Immunol Immunopathol; 2005 Oct 18; 108(1-2):11-6. PubMed ID: 16098606
    [Abstract] [Full Text] [Related]

  • 9. Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells.
    Sivori S, Carlomagno S, Moretta L, Moretta A.
    Eur J Immunol; 2006 Apr 18; 36(4):961-7. PubMed ID: 16525994
    [Abstract] [Full Text] [Related]

  • 10. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.
    Ballas ZK, Rasmussen WL, Krieg AM.
    J Immunol; 1996 Sep 01; 157(5):1840-5. PubMed ID: 8757300
    [Abstract] [Full Text] [Related]

  • 11. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
    Giordani L, Sanchez M, Libri I, Quaranta MG, Mattioli B, Viora M.
    J Leukoc Biol; 2009 Aug 01; 86(2):261-71. PubMed ID: 19401392
    [Abstract] [Full Text] [Related]

  • 12. Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration.
    Heikenwalder M, Polymenidou M, Junt T, Sigurdson C, Wagner H, Akira S, Zinkernagel R, Aguzzi A.
    Nat Med; 2004 Feb 01; 10(2):187-92. PubMed ID: 14745443
    [Abstract] [Full Text] [Related]

  • 13. Augmentation of T(H)-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling.
    Shimosato T, Kitazawa H, Katoh S, Tohno M, Iliev ID, Nagasawa C, Kimura T, Kawai Y, Saito T.
    Biochem Biophys Res Commun; 2005 Jan 28; 326(4):782-7. PubMed ID: 15607737
    [Abstract] [Full Text] [Related]

  • 14. A Toll-like receptor recognizes bacterial DNA.
    Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S.
    Nature; 2000 Dec 07; 408(6813):740-5. PubMed ID: 11130078
    [Abstract] [Full Text] [Related]

  • 15. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release.
    Hong Z, Jiang Z, Liangxi W, Guofu D, Ping L, Yongling L, Wendong P, Minghai W.
    Int Immunopharmacol; 2004 Feb 07; 4(2):223-34. PubMed ID: 14996414
    [Abstract] [Full Text] [Related]

  • 16. CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs.
    Gray RC, Kuchtey J, Harding CV.
    J Leukoc Biol; 2007 Apr 07; 81(4):1075-85. PubMed ID: 17227820
    [Abstract] [Full Text] [Related]

  • 17. [Toll-like receptor 9 in cpG oligodeoxynucleotides-induced species-specific immune responses].
    Li N, Fan XG, Tang SE, Zhu C.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct 07; 30(5):533-5. PubMed ID: 16320582
    [Abstract] [Full Text] [Related]

  • 18. The immunostimulatory activity of CpG oligonucleotides on microglial N9 cells is affected by a polyguanosine motif.
    Zhang Z, Guo K, Schluesener HJ.
    J Neuroimmunol; 2005 Apr 07; 161(1-2):68-77. PubMed ID: 15748945
    [Abstract] [Full Text] [Related]

  • 19. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F, Hermann P, Nakashima K, Matsukawa S, Sakai K, Bacon KB.
    Eur J Immunol; 2003 Jun 07; 33(6):1576-85. PubMed ID: 12778475
    [Abstract] [Full Text] [Related]

  • 20. Novel immunostimulatory phosphodiester oligodeoxynucleotides with CpT sequences instead of CpG motifs.
    Kim D, Jung J, Lee Y, Kwon HJ.
    Mol Immunol; 2011 Jul 07; 48(12-13):1494-504. PubMed ID: 21529949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.